High post‐treatment serum soluble receptor‐binding cancer antigen expressed on SiSo cells (sRCAS1) levels is associated with poor survival of patients with cervical cancer
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Obstetrics and Gynaecology Research"
DOI: 10.1111/jog.14178
Abstract: Receptor‐binding cancer antigen expressed on SiSo cells (sRCAS1) is responsible for induction of selective immunosuppression. In addition, preclinical studies have shown that sRCAS1 levels may reflect cancer aggressiveness. The main aim of our study was… read more here.
Keywords: treatment; antigen expressed; cancer; receptor binding ... See more keywords